Krebs Biochemicals & Industries Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Krebs Biochemicals & Industries Ltd with 125 companies shown from the same industry classification, including Alpa Laboratories Ltd, Achyut Healthcare Ltd, Lactose (India) Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Krebs Biochemicals & Industries Ltd | 125 Cr. | 57.8 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 121 Cr. | 57.7 | 99.8/46.0 | 27.8 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.47 | 10.0/4.70 | 413 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 139 Cr. | 9.49 | 14.3/1.96 | 46.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 141 Cr. | 129 | 135/69.7 | 36.2 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 108 Cr. | 30.5 | 53.9/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Vaishali Pharma Ltd | 104 Cr. | 7.99 | 11.5/4.75 | 24.6 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Auro Laboratories Ltd | 147 Cr. | 236 | 317/159 | 30.8 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Par Drugs & Chemicals Ltd | 149 Cr. | 121 | 180/78.0 | 10.3 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Concord Drugs Ltd | 93.5 Cr. | 71.0 | 92.5/61.0 | 45.8 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Bal Pharma Ltd | 157 Cr. | 98.6 | 125/59.7 | 21.8 | 51.6 | 1.22 % | 9.75 % | 7.79 % | 10.0 |
| Denis Chem Lab Ltd | 90.7 Cr. | 65.4 | 94.6/56.1 | 11.4 | 66.0 | 3.83 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Brooks Laboratories Ltd | 173 Cr. | 58.8 | 132/36.3 | 13.1 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Fervent Synergies Ltd | 74.4 Cr. | 14.9 | 26.0/13.0 | 20.4 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 63.6 Cr. | 25.4 | 25.4/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Vivimed Labs Ltd | 58.3 Cr. | 6.91 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Coral Laboratories Ltd | 193 Cr. | 540 | 679/360 | 10.2 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 49.8 Cr. | 31.5 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.5 Cr. | 30.4 | 46.8/25.6 | 103 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| ANG Lifesciences India Ltd | 48.4 Cr. | 37.1 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 204 Cr. | 10.5 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.44/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bharat Immunological & Biological Corporation Ltd | 38.2 Cr. | 8.84 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Bacil Pharma Ltd | 34.8 Cr. | 24.2 | 61.8/10.6 | 53.5 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.8 Cr. | 38.2 | 53.0/29.7 | 9.45 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.6 Cr. | 35.4 | 59.8/29.0 | 12.4 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.3 Cr. | 31.6 | 144/28.4 | 14.1 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.6 Cr. | 91.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Gennex Laboratories Ltd | 237 Cr. | 9.77 | 17.2/7.05 | 12.6 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Beryl Drugs Ltd | 12.8 Cr. | 25.2 | 27.6/15.9 | 20.7 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 10.2 Cr. | 3.89 | 25.0/3.89 | 3.89 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Everest Organics Ltd | 241 Cr. | 242 | 536/197 | 45.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Brawn Biotech Ltd | 7.62 Cr. | 25.4 | 25.7/17.7 | 8.96 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Decipher Labs Ltd | 5.75 Cr. | 5.69 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.22 Cr. | 0.79 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| Evoq Remedies Ltd | 4.08 Cr. | 1.64 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Lyka Labs Ltd | 262 Cr. | 72.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 274 Cr. | 475 | 610/340 | 23.4 | 134 | 1.05 % | 20.5 % | 14.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 330 Cr. | 102 | 110/50.3 | 79.0 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Albert David Ltd | 464 Cr. | 813 | 932/580 | 20.6 | 686 | 0.62 % | 0.82 % | 0.44 % | 10.0 |
| Wanbury Ltd | 679 Cr. | 194 | 360/162 | 15.8 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Anuh Pharma Ltd | 820 Cr. | 81.6 | 99.5/66.7 | 18.6 | 35.1 | 1.83 % | 14.9 % | 10.7 % | 5.00 |
| Kilitch Drugs (India) Ltd | 845 Cr. | 242 | 268/117 | 28.1 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 951 Cr. | 402 | 409/94.8 | 122 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,003 Cr. | 109 | 147/65.0 | 43.3 | 0.46 % | 2.74 % | 0.41 % | 1.00 | |
| Lincoln Pharmaceuticals Ltd | 1,121 Cr. | 560 | 770/440 | 11.6 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Kopran Ltd | 1,237 Cr. | 256 | 296/107 | 49.5 | 110 | 1.17 % | 6.65 % | 4.91 % | 10.0 |
| TTK Healthcare Ltd | 1,423 Cr. | 1,007 | 1,250/735 | 18.6 | 789 | 0.99 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,508 Cr. | 522 | 760/476 | 24.2 | 128 | 0.94 % | 24.8 % | 18.4 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,553 Cr. | 235 | 265/155 | 33.0 | 41.2 | 1.70 % | 22.7 % | 17.3 % | 2.00 |
| Fermenta Biotech Ltd | 1,587 Cr. | 540 | 583/249 | 29.0 | 138 | 0.69 % | 20.6 % | 16.4 % | 5.00 |
| Hester Biosciences Ltd | 1,844 Cr. | 2,167 | 2,684/1,239 | 34.7 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Panacea Biotec Ltd | 2,124 Cr. | 347 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Beta Drugs Ltd | 2,208 Cr. | 1,991 | 2,808/990 | 48.4 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,217 Cr. | 23.6 | 27.5/10.2 | 26.2 | 4.39 | 0.42 % | 24.8 % | 17.6 % | 1.00 |
| Indoco Remedies Ltd | 2,276 Cr. | 247 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Venus Remedies Ltd | 2,292 Cr. | 1,681 | 2,044/432 | 19.7 | 497 | 0.59 % | 20.7 % | 15.6 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,390 Cr. | 152 | 306/128 | 132 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Fredun Pharmaceuticals Ltd | 2,529 Cr. | 1,532 | 1,666/454 | 56.9 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Hikal Ltd | 2,777 Cr. | 225 | 261/146 | 65.5 | 97.2 | 0.27 % | 3.50 % | 2.21 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,024 Cr. | 270 | 420/252 | 19.2 | 146 | 1.98 % | 14.0 % | 10.2 % | 2.00 |
| Solara Active Pharma Sciences Ltd | 3,185 Cr. | 656 | 774/422 | 746 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,401 Cr. | 391 | 425/87.0 | 52.3 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,663 Cr. | 3,530 | 3,949/829 | 44.8 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Unichem Laboratories Ltd | 3,744 Cr. | 531 | 687/278 | 30.6 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Aarti Drugs Limited | 3,811 Cr. | 418 | 534/319 | 22.0 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| SMS Pharmaceuticals Ltd | 4,203 Cr. | 449 | 494/264 | 46.4 | 85.9 | 0.09 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,237 Cr. | 423 | 468/268 | 57.6 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Zota Health Care Ltd | 4,580 Cr. | 1,322 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| RPG Life Sciences Ltd | 4,665 Cr. | 2,821 | 3,130/1,731 | 40.0 | 366 | 0.82 % | 25.7 % | 19.3 % | 8.00 |
| Gujarat Themis Biosyn Ltd | 4,812 Cr. | 370 | 479/225 | 98.9 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| FDC Ltd | 5,349 Cr. | 329 | 474/313 | 17.4 | 153 | 1.52 % | 15.4 % | 11.2 % | 1.00 |
| Orchid Pharma Ltd | 5,876 Cr. | 981 | 1,144/471 | 325 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,464 Cr. | 220 | 224/67.1 | 36.6 | 61.3 | 0.45 % | 11.3 % | 8.42 % | 2.00 |
| Sanofi India Ltd | 6,864 Cr. | 2,982 | 4,898/2,967 | 20.0 | 359 | 2.52 % | 57.5 % | 43.0 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,247 Cr. | 682 | 745/118 | 52.7 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Entero Healthcare Solutions Ltd | 7,349 Cr. | 1,689 | 1,920/944 | 57.0 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Morepen Laboratories Ltd | 7,485 Cr. | 137 | 151/33.0 | 63.8 | 22.8 | 0.14 % | 8.05 % | 5.33 % | 2.00 |
| Aarti Pharmalabs Ltd | 7,975 Cr. | 880 | 1,002/584 | 37.0 | 234 | 0.38 % | 10.7 % | 8.59 % | 5.00 |
| Suven Life Sciences Ltd | 8,124 Cr. | 288 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Procter & Gamble Health Ltd | 8,574 Cr. | 5,166 | 6,975/4,700 | 25.7 | 316 | 2.99 % | 83.9 % | 61.9 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Blue Jet Healthcare Ltd | 9,824 Cr. | 519 | 693/325 | 41.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Concord Biotech Ltd | 13,948 Cr. | 1,331 | 1,627/987 | 49.0 | 193 | 0.57 % | 17.4 % | 12.6 % | 1.00 |
| Marksans Pharma Ltd | 13,976 Cr. | 308 | 351/155 | 27.0 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,795 Cr. | 5,918 | 9,850/5,802 | 85.3 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| Jubilant Pharmova Ltd | 15,525 Cr. | 975 | 1,185/784 | 40.0 | 445 | 0.51 % | 8.99 % | 6.53 % | 1.00 |
| Natco Pharma Ltd | 15,615 Cr. | 796 | 1,217/786 | 13.8 | 470 | 0.62 % | 17.4 % | 17.1 % | 2.00 |
| ERIS Lifesciences Ltd | 15,897 Cr. | 1,146 | 1,740/1,141 | 24.2 | 282 | 0.63 % | 14.1 % | 18.7 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,389 Cr. | 834 | 998/635 | 22.0 | 289 | 1.44 % | 12.6 % | 13.4 % | 2.00 |
| Cohance Lifesciences Ltd | 16,932 Cr. | 443 | 918/267 | 157 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,073 Cr. | 3,732 | 5,578/3,732 | 22.2 | 919 | 1.96 % | 24.1 % | 18.0 % | 10.0 |
| Caplin Point Laboratories Ltd | 20,136 Cr. | 2,649 | 2,991/1,500 | 30.3 | 443 | 0.30 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,145 Cr. | 1,030 | 1,096/260 | 70.9 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Granules India Ltd | 23,058 Cr. | 845 | 924/520 | 35.5 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Acutaas Chemicals Ltd | 25,039 Cr. | 3,057 | 3,740/1,380 | 64.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Neuland Laboratories Ltd | 26,987 Cr. | 21,034 | 24,235/11,500 | 54.3 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Wockhardt Ltd | 33,005 Cr. | 2,030 | 2,422/1,087 | 82.8 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,642 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,608 Cr. | 3,570 | 3,797/2,380 | 39.3 | 362 | 0.90 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,622 Cr. | 2,634 | 3,121/2,088 | 42.4 | 134 | 2.16 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 49,181 Cr. | 1,938 | 2,039/1,252 | 35.8 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 51,988 Cr. | 3,151 | 3,171/1,574 | 36.8 | 656 | 0.63 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 54,310 Cr. | 25,550 | 30,655/25,135 | 33.6 | 2,247 | 2.05 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 58,669 Cr. | 360 | 447/338 | 80.7 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Glenmark Life Sciences Ltd | 62,243 Cr. | 2,210 | 2,538/1,793 | 20.0 | 372 | 0.23 % | 39.8 % | 23.6 % | 1.00 |
| Alkem Laboratories Ltd | 63,973 Cr. | 5,350 | 5,934/5,051 | 28.2 | 1,156 | 0.99 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 64,412 Cr. | 2,282 | 2,538/1,793 | 20.6 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 88,806 Cr. | 1,942 | 2,530/1,900 | 14.9 | 491 | 0.89 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 94,309 Cr. | 1,642 | 1,740/1,075 | 24.9 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 98,508 Cr. | 2,380 | 2,642/1,910 | 43.6 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,479 Cr. | 1,204 | 1,415/1,080 | 31.2 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Cipla Ltd | 1,07,221 Cr. | 1,327 | 1,673/1,166 | 30.0 | 426 | 0.98 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,08,062 Cr. | 2,000 | 2,065/843 | 124 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,75,851 Cr. | 4,617 | 5,250/3,480 | 78.8 | 248 | 0.82 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,219.37 Cr | 1,223.50 | 53.77 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Krebs Biochemicals & Industries Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Krebs Biochemicals & Industries Ltd analysis · Explore all Pharmaceuticals stocks